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Electrical isolation of pulmonary veins using
cryothermal energy: study design and initial
resuIts
M.F. Scholten, G.J. Kinman, P.A. Janse, A.S. Thornton, D.A.M.J. Theuns, L.J. Jordaens
Background. Atrial fibrillation (AF) is the most
frequently encountered arrhythmia. Radiofre-
quency pulmonary vein (PV) ablation is promising
for symptomatic paroxysmal AF, but is associated
with a significant risk ofPV stenosis.
Objectives. To assess the efficacy ofcryothermal PV
ablation and the incidence ofPV stenosis.
Methods. Highly symptomatic patients with parox-
ysmal or persistentAF were digible for cryothermal
ablation. Multislice spiral CT scans were performed
before, and three months after ablation. AF burden
was assessed using transtelephonicECG recording
and by telephonic enquiry.
Results. An attempt was made to isolate 27 PVs in
15 patients. In total, 20 PVs could be isolated (74%
acute success). No significant difference in PV
diameter was seen before and after ablation. Five
out of 12 patients with paroxysmal AF were com-
pletely without AF after one ablation procedure.
An additional two patients reported a significant
reduction in symptoms. In the three patients with
persistent AF no improvement was reported.
Conclusion. CryothermalPV ablation was effective
in isolation of the targeted PVs. It appears to be
safe, as no PV stenosis was seen in this study three
months after the ablation. Taking into account a
leaming curve, we consider the clinical results to
be very promising. (NethHeartJ2003;1 1:341-6.)
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Atrial fibrillation (AF) is the most frequently
encountered sustained arrhythmia in clinical
practice. The pulmonary veins are an important source
ofectopic beats, which appear to be the main initiator
of paroxysms of atrial fibrillation.' The myocardial
architecture (arrangement ofmyocardial cells, fibrosis)
in normal pulmonary veins is highly variable and
responsible for non-uniform anisotropic properties.2
Successful surgical treatment ofAF always includes
isolation ofthe pulmonary veins.3'4 Empiric catheter-
based pulmonary vein (PV) isolation appears to be a
promising approach for maintaining sinus rhythm in
patients with paroxysmal AF.56 However, the pro-
cedure is associated with a significant risk (4 to 8.9%
oftreated patients) ofpulmonary vein stenosis, defined
as a luminal diameter reduction of 50% or more.7-"
Luminal diameter reduction between 25 and 50% was
found in 16% oftreated patients.7 PV stenosis can be
life-threatening.'2 The aims ofour studywere twofold.
Firstly we wanted to assess the efficacy ofcryothermal
PV ablation. A further objective was to measure the
incidence ofPV stenosis using cryothermal energy.
Methods
Patients with a history ofproblematic AF referred to
the department of clinical electrophysiology were
considered candidates for this single-centre prospective
study. Initially, patients with persistent AF were also
included. Entry criteria for paroxysmal AF included
symptomatic episodes, occurring at least monthly,
despite the use ofmore than two antiarrhythmic drugs.
Exclusion criteria included severe valvular disease,
marked left atrial enlargement (>50 mm, measured
on M-mode echocardiography) and contraindications
for oral anticoagulation. The day before the procedure
a transoesophageal echocardiogram was performed to
exclude left atrial thrombi. Antiarrhythmic drugs were
continued.
Ablation
During the first ablation procedures an attempt was
made to isolate the left upper PV (LUPV) and right
upper PV (RUPV). A decapolar catheter was inserted
in the coronary sinus (CS) via the left subclavian vein.
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Figure 1. Basket catheter positioned together with the ablation
catheter in the left upperpulmonary vein.
A bipolar catheter was advanced in the right ventricular
apex and was used as the reference catheter for a 3D
positioning system (Localisa).'3 Double transseptal
puncture was performed guided by intracardiac
echocardiography.'4 After transseptal puncture the
Figure 3. Use of the Localisa 3D positioning system. On the left
side ofthe image thepositions ofablation applications in the tight
upperpulmonary vein are saved. On the right side ofthe image a
ring of eketrodes from the Basket catheter in the left upper
pulmonary vein (LUPV) is made visible. The ablation catheter is
seen within this ring at the position of the first cryothermal
application in the LUPV.
Figure 2. Pacing in the coronary sinus before and after successful
ablation. In the leftpanelan atrialsignalfollowed byapulmonary
vein potential is seen. In the mghtpanel the pacing signal is only
followed by an atrial signal.
patients were heparinised, guided by the activated
clotting time (ACT). After making a selective veno-
gram a multipolar basket catheter (Constellation,
Boston Scientific, Natick, MA, US) was advanced into
the pulmonary vein (figure 1). The electrical con-
nection between left atrium (LA) and PVs before and
after ablation was studied while pacing from the CS
(figure 2). Positioning ofthe ablation catheter within
the PV was guided by fluoroscopy, electrograms and
the Localisa system (figure 3).The pulmonary veins
were ablated at the venoatrial junction, aiming at
electrical isolation ofthe veins (figure 4). Ablation was
performed with a 7-French 6 mm tip Freezor-Xtra
cryocatheter (Cryocath Technologies Inc., Kirkland,
Quebec, Canada). Applications lasted four minutes
i. -X.- -'-1i-i
9-. 27-1 S7.
Figure 4. Disappearance ofpulmonary vein potentials (PVP)during ablation. The first three atrial potentiak during sinus
rhyyhm arefollowedbya PVP. The lastatrialpotential is no longer
followed by a PVP. Tbis PVP did not return and thispulmonary
vein was therefvre succesfully electrieal1y isolated.
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each. After the ablation, patients were hospitalised for Follow-up
at least two days and followed for early recurrences. In hospital recurrences ofAF were documented. After
Heparin was continued and anticoagulation treatment discharge the patients were followed in the outpatient
(acenocoumarol) started. If the patients remained clinic on a regular basis. Transtelephonic ECG record-
symptomatic after three months the persistence of ings were made weekly and in case of symptomatic
electrical isolation ofthe successfillly treated PVs was arrhythmias. Furthermore at three months, the patients
to be confirmed, and the other PVs ablated. were interviewed by telephone by a research nurse
Table 2. Ablation data.
No. LUPV Diam. Appi. Isolated RUPV Diam. Appi. Isolated UPV Diam. Appi. Isolated
(mm) (no.) (mm) (no.) (mm) (no.)
1 + 18 2
2 + 15 13
3 + 19 16
4 + 21 17
5 + 18 3
6 + 15 NA
7 + NA 6
8 + 18 8
9 + NA 6
10 + NA 3
11 + 22 7
12 + 22 NA
13 + 19 0
14 + 21 11
15 + 15 9
+
+
+
+
+
+
+
+
+
+
+
+
17
+ 15 NA
19
- 18
+ NA 8
+ 19 10
+ NA 5
18
+ NA
- NA
+
5 +
18 5
18 NA
18 13
19 8
17 15
+ 17 3
- 21
19
+ 19 2
17
15
- NA
- 18
- NA
+ NA 8
- 18
17
17
13
15
Appl.=application; diam=diameter; LIPV=left inferior pulmonary vein; LUPV=left upper pulmonary vein; NA=not available; RUPV=right upper pulmonary vein.
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Table 1. Patient characteristics before catheter ablation.
No. Gender Age ParoxysmaV/ Cardiac disease Attack pattem Cardloversions Cardloversions
(year) persistent before after
1 Male 63 1 - M 15 1
2 Male 57 1 DCM D 1 0
3 Male 56 1 - D 0 0
4 Female 68 1 Thyroid W 0 1
5 Male 51 2 - P 3 0
6 Male 59 1 - W 8 0
7 Female 62 1 Thyroid D 0 0
8 Male 52 1 - D 1 0
9 Female 40 1 Valv. W 0 0
10 Male 56 1 H/DM M 7 0
11 Male 50 2 H P 1 0
12 Male 40 1 Thyroid P 15 1
13 Male 53 1 Valv. D 2 0
14 Male 45 1 - D 1 1
15 Female 40 1 - W 0 2
1=paroxysmal; 2=persistent; D=Daily, DCM=dilated cardiomyopathy; DM=diabetes mellitus; H=hypertension; M=monthly, Valv=valvular disease; W=weekly.
+
+
+
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249
322
364
212
281
396
194
335
254
255
227
297
297
72.8
68.8
80.3
56.3
58.9
110
45.3
69.1
49.5
64.3
45
59.4
55.1
yes PE, no puncture
yes hypotension
D
w
w
D
D
D
Table 3. Additional procedure data and follow-up.
No. istmus Remarks Proc. time Fluroscopy
(minutes) (minutes)
I
2
3
4
5
6
7
8
9
10
11
12
13 yes ST elevation inferior
Amaurosis fugax
14 + one left vein 299 53.6 yes ST elevation inferior
15 272 50.2 M
D=daily, M=monthly, PE=pericardial effusion; Proc.=procedure; W=weekly; +=associated flutter ablation and cavo-tricuspid isthmus block achieved, -=no AF attacks
after PV ablation.
yes ST elevation inferior
D
D
about their subjective wellbeing. Before, and three
months after the ablation, the diameter of all pul-
monary veins was measured using multislice spiral CT
scans. A one-year CT scan is scheduled in all patients.
Results
Patients
Results from the first ablation ofthe initial 15 patients
included in this study are reported. Their demographic
and clinical data are summarised in table 1. The mean
age was 52.8 years (40 to 68 years), and four were
female. Their mean IA size measured with M-mode
echocardiography was 40.9 mm (30 to 48 mm). Ten
patients had been cardioverted once or more in the
past and six of them had daily attacks ofAF.
Ablation
Acute results of the ablation are shown in table 2. An
attempt was made to isolate 27 PVs, ofwhich 20 veins
could be isolated (74% acute success). The mean
fluoroscopy time was 62.6 minutes and the mean
procedural time 285 minutes (table 3). An average
number of 7.71 (1 to 17) applications per vein was
necessary.
Although it was the intention to treat only the
LUPV and RUPV, because ofprocedural reasons the
left inferior PV (LIPV) was occasionally targeted
instead of the RUPV (n=2) or as a third PV (n=1).
Multislice spiral CT scan
Using multislice CT angiography (MSCT) of the
treated vessels no significant difference in PV diameter
before and three months after PV ablation was seen:
LUPV 18.58x2.61 mmversus 18.13x2.10 mm; LIPV
17.17x2.12 mm versus 17.00x3.59 mm; RUPV
17.55x1.44 mm versus 18.19x0.95 mm.
Complications
Complications are shown in table 3. One patient had a
pericardial effusion, not requiring puncture. Temporary
ST-segment elevation in the inferior leads after selective
angiography ofthe PV (LUPV and RUPV) was seen
in three patients. In one patient a very short episode
ofblurred vision occurred on the second day after the
procedure. No other complications occurred.
Follow-up
Mean follow-up was 276 days (104 to 426 days). Five
of 12 patients (42%) with paroxysmal AF were com-
pletely without AF after one ablation procedure. An
additional two patients (17%) reported a 50% reduction
in symptoms. In the three patients with persistent AF
no improvement was reported. The evolution in the
AF burden is shown in table 3.
Discussion
It has been shown that extensions of atrial muscle
surrounding the pulmonary veins (PVs) can have
ectopic electrical activity able to trigger AF.25 The
long-term success rate of RF ablation (RFA) to cure
AF by targeting these initiators using a focal approach
is low (29%).18 Empiric PV isolation appears to be a
more effective approach to the maintenance of sinus
rhythm.5 6 Although distal isolation can be achieved
with fewer lesions, ostial isolation is required in the
Netherlands Heart Journal, Vohune 11, Number 9, September 2003
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majority of patients to eliminate arrhythmogenic
activity and AF.18 It has become clear that electrical
isolation of all four pulmonary veins from the left
atrium provides the best cure rate. However, this is
associated with a significant risk of pulmonary vein
stenosis,9- 1 which has serious consequences, and can
occur very late after the procedure (1 to 2 years).8
Cryothermal ablation
Cryothermal tissue injury is distinguished from
hyperthermic injury, such as caused by RF energy, by
the preservation ofbasic underlying tissue architecture
and minimal thrombus formation. We hypothesised
that using cryothermal energy would prevent the
occurrence ofPV stenosis. Cryothermal ablation, with
a different set-up, was formerly used for this indication
and seems to be safe.'9
Results ofPV ablation
Reported results ofPV ablation show a large variability
and are also dependent on the definitions used for the
endpoints. Recently Oral et al.20 reported results ofPV
ablation (with at least three PVs ablated ) in 70 patients.
After a mean follow-up of five months 70% of the
patients with paroxysmalAF were in sinus rhythm (SR),
compared with only 22% with persistent AF. A lower
success rate of 51% after a mean follow-up of nine
months was reported by Deisenhofer." Gerstenfeld et
al.'0 reported a very high recurrence rate of68%. After
10.4±4.5 months, 85% ofpatients with paroxysmal AF
and 68% ofpatients with permanent AF were in SRin
a report by Pappone21 using circumferential RF
ablation.
Complications ofPV ablation/PV stenosis
The risk of pulmonary vein (PV) stenosis after PV
ablation is significant.22'23 Metaplasia, proliferation,
thrombosis and neovascularisation may lead to PV
stenosis after RF energy application around or inside
the PV ostia.9 Pulmonary vein stenosis is potentially
life-threatening.24 The clinical manifestations of PV
stenosis consist of chest pain, dyspnoea, cough,
haemoptysis, recurrent lung infection and pulmonary
hypertension. PV stenosis can be asymptomatic. Some
patients may show late progression of PV stenosis
during follow-up.8'9 In a recent series of 380 ablated
veins, the CT scans revealed 2 PVs (1%) with severe
(>70%) stenosis, 13 (3%) with moderate (51 to 70%)
stenosis, and 62 (16%) with mild (<50%) stenosis.7 In
a recent report on 75 patients, Deisenhofer found
stenosis of25 to 50% in 9.3% patients and of >50% in
8.9% patients." Others estimate the incidence ofPV
stenosis (defined as luminal diameter reduction >50%)
detected by spiral computer tomography scan or three
dimensional magnetic resonance angiography) at 0 to
7% per PV ablated.9
Moderate PV stenosis (50% narrowing) was
observed in one of 136 consecutive patients (0.7%)
after RF ablation ofPV using an irrigated-tip catheter.25
Using cryothermal ablation Rodriguez'9 found no
stenosis after PV ablation in 53 veins. PV stenosis can
be treated with balloon dilation, although the long-term
course is unknown.26
Pericardial effusion
Pericardial effusion is reported in almost all reports
about PV ablation.27 Deisenhofer reported pericardial
effusion in 4 of 75 patients (5.3%).11 We suspect that
catheter manipulation within the left or right atrium
or damage to the thin-walled left atrial appendage is
responsible.
Other complications ofPV ablation
Other less frequently described complications such as
phrenic nerve paralysis and reflex bradycardia were not
observed in our series.28
Future perspectives
Several authors have explained the modest effect ofPV
ablation by the existence of non-PV foci.29'30 Repeat
ablation procedures are necessary in almost 50% of
patients.25 The role of concomitant cavotricuspid
isthmus ablation and creation ofa linear lesion (referred
to as the 'lateral mitral isthmus line') between the
ostium ofthe left inferior PV and lateral mitral annulus2'
needs to be defined. These lesions may reduce the
amount ofatrium available to support multiple wavelet
reentry, changing the substrate for AF.
Conclusion
This report shows the initial results ofthe first patients
in our department ever treated with PV ablation for
paroxysmal AF. In 5 of 12 (42%) patients with parox-
ysmalAF no recurrences ofAF occurred. An additional
2 of these 12 (17%) reported a 50% reduction in
symptoms. Taking into account a learning curve, we
consider these results promising. Cryothermal PV
ablation appears to be a safe method. No PV stenosis
was seen in this study three months after the ablation.
Numbers are, of course, still too low to make firm
conclusions. However the absence ofpulmonary vein
stenosis three months after ablation of 27 veins is
encouraging. Furthermore this report is about the
initial procedure in every patient. Ofinterest is that it
appears there is a subset ofpatients who report a sig-
nificant improvement in AF burden after PV ablation
although AF did return. All patients with recurrence
ofAF were offered a second procedure to evaluate
invasively the results of their first treatment and to
extend the ablation to the two inferior PVs. U
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